Home › Gestational Diabetes › NCT04206748
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes: a Pilot Randomized, Controlled Trial
Who can join
Ages 18 and older · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria * All patients \>/= women 18 years of age with gestational diabetes or type 2 diabetes during pregnancy and identified by the research team and consented before 30.6 weeks. * Non-anomalous singletons * Ability to provide informed consent Exclusion Criteria * Patients with Type 1 diabetes * Patients with fetal major congenital abnormalities * Patients identified/referred after 30.6 weeks
About the study
The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
What is being tested
- iGlucose Smart Meter System (device)
- Routine Care-RX meter (device)
Sponsor: The University of Texas Health Science Center, Houston · Participants: 200 · Started: Nov 12, 2019
Contact the study team
- Joycelyn Corthwaite, RD · Phone: 832-325-7205
- Clara Ward, MD · Phone: 713-500-6412
Official record on ClinicalTrials.gov — NCT04206748
Locations in the U.S.
| Texas | The University of Texas Health Science Center at Houston, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.